Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$37,000.00

Engineering polyplex-mediated large-scale transfection

FY 2011-12

Summary
SUMMARY. Large-scale transfection of HEK293 (293) and CHO cells is becoming an established technology to rapidly produce milligram to gram quantities of biologically active recombinant proteins in less than 2 weeks following cDNA cloning into the expression plasmid. However, this technology still suffers from significant limitations in terms of transfection efficiency and volumetric productivity. For example, while stable CHO cell line can generate 1-3 grams per liter quantities of monoclonal antibodies, the best yields reported for transient expression are in the 100-300 mg/L range. Improving the titers of the transient expression technology will make it useable for the generation of clinical grade material. This research program aims at better understanding the transfection process and improving the technology by tackling the main barriers to an efficient transfection through three approaches: 1- Understanding and maximizing cellular uptake of plasmid DNA: Members of the cell-surface heparan sulphate proteoglycan family will be evaluated for their ability to offer transfection-effective polyplex binding sites at the cell surface. 2- Increasing nuclear targeting of plasmid DNA: Polyplex will be decorated with ligands targeting cell-surface receptors known to undergo nuclear translocation following activation. Another approach will be to decorate polyplexes with nuclear localisation sequence. 3- Improving endosomal escape of plasmid DNA: Polyplex will be decorated with fusogenic peptides or viral proteins that promote endosome escape, one of the major limiting step in transfection. The ultimate goal of this research project aim at developing a robust and cost-effective large-scale transfection process for accelerating biotherapeutic discovery and development.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
327349-2009
Name nom
Durocher, Yves
Department département
Biochimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
37000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
3
Nb partie
5
Application title
Engineering polyplex-mediated large-scale transfection
Keyword
NSERC
Application summary
SUMMARY. Large-scale transfection of HEK293 (293) and CHO cells is becoming an established technology to rapidly produce milligram to gram quantities of biologically active recombinant proteins in less than 2 weeks following cDNA cloning into the expression plasmid. However, this technology still suffers from significant limitations in terms of transfection efficiency and volumetric productivity. For example, while stable CHO cell line can generate 1-3 grams per liter quantities of monoclonal antibodies, the best yields reported for transient expression are in the 100-300 mg/L range. Improving the titers of the transient expression technology will make it useable for the generation of clinical grade material. This research program aims at better understanding the transfection process and improving the technology by tackling the main barriers to an efficient transfection through three approaches: 1- Understanding and maximizing cellular uptake of plasmid DNA: Members of the cell-surface heparan sulphate proteoglycan family will be evaluated for their ability to offer transfection-effective polyplex binding sites at the cell surface. 2- Increasing nuclear targeting of plasmid DNA: Polyplex will be decorated with ligands targeting cell-surface receptors known to undergo nuclear translocation following activation. Another approach will be to decorate polyplexes with nuclear localisation sequence. 3- Improving endosomal escape of plasmid DNA: Polyplex will be decorated with fusogenic peptides or viral proteins that promote endosome escape, one of the major limiting step in transfection. The ultimate goal of this research project aim at developing a robust and cost-effective large-scale transfection process for accelerating biotherapeutic discovery and development.